Pharmacologic strategies to reduce cardiovascular disease in type 2 diabetes mellitus: focus on SGLT ‐2 inhibitors and GLP ‐1 receptor agonists-Reference-Cited by-同舟云学术

Pharmacologic strategies to reduce cardiovascular disease in type 2 diabetes mellitus: focus on SGLT ‐2 inhibitors and GLP ‐1 receptor agonists

Published:2019-03-19 Issue:1 Volume:286 Page:16-31
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Bonaventura A.¹²^ORCID,Carbone S.²^ORCID,Dixon D. L.³^ORCID,Abbate A.²,Montecucco F.⁴⁵^ORCID

Affiliation:

1. the First Clinic of Internal Medicine Department of Internal Medicine University of Genoa Genoa Italy

2. Division of Cardiology Department of Internal Medicine Virginia Commonwealth University Pauley Heart Center Richmond Virginia USA

3. Department of Pharmacotherapy and Outcomes Science Virginia Commonwealth University Richmond VA USA

4. First Clinic of Internal Medicine Department of Internal Medicine and Centre of Excellence for Biomedical Research (CEBR) University of Genoa Genoa Italy

5. IRCCS Ospedale Policlinico San Martino –Italian Cardiovascular Network Genoa Italy

Funder

Rete Cardiologica, Ministero della Salute, Italy

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/joim.12890

Reference78 articles.

1. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040

2. Estimating the real‐world cost of diabetes mellitus in the United States during an 8‐year period using 2 cost methodologies;Willey VJ;Am Health Drug Benefits,2018

3. Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study

4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

5. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of the sodium‐glucose cotransporter‐2 inhibitor, DWP16001, as an add‐on therapy to insulin for diabetic dogs: A pilot study;Veterinary Medicine and Science;2024-04-30

2. Primordial Drivers of Diabetes Heart Disease: Comprehensive Insights into Insulin Resistance;Diabetes & Metabolism Journal;2024-01-31

3. Targeting mitochondrial quality control for diabetic cardiomyopathy: Therapeutic potential of hypoglycemic drugs;Biomedicine & Pharmacotherapy;2023-12

4. Diabetic cardiomyopathy: Clinical phenotype and practice;Frontiers in Endocrinology;2022-12-07

5. The effect of liraglutide on renal function in type 2 diabetes: a meta-analysis of randomized controlled studies;African Health Sciences;2022-10-27